Watchlist Price Alert

Rapport Therapeutics Inc.... (RAPP)

NASDAQ: RAPP · Real-Time Price · USD

11.32

-0.15 (-1.31%)

At close: May 02, 2025, 3:59 PM

11.33

0.09%

After-hours: May 02, 2025, 04:05 PM EDT

Rapport Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-78.31M	-34.79M	-10.65M
Depreciation & Amortization	839K	112K	15K
Stock-Based Compensation	10.23M	3.52M	n/a
Other Working Capital	-2.07M	1.8M	1.49M
Other Non-Cash Items	4.82M	1.32M	5.94M
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	-2.42M	2.65M	1.49M
Operating Cash Flow	-64.83M	-27.18M	-3.24M
Capital Expenditures	-2.4M	-1.64M	-284K
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	-380.74M	-77.22M	n/a
Sales Maturities Of Investments	209.8M	n/a	n/a
Other Investing Acitivies	3.21M	n/a	-5M
Investing Cash Flow	-170.14M	-78.86M	-5.28M
Debt Repayment	n/a	n/a	7.9M
Common Stock Repurchased	n/a	-4K	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	7K	-134K	n/a
Financial Cash Flow	221.63M	145.14M	39.69M
Net Cash Flow	-13.34M	39.09M	31.16M
Free Cash Flow	-67.23M	-28.82M	-3.53M